These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 2136863

  • 1. Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia.
    Jin H, Yang RH, Chen YF, Jackson RM, Oparil S.
    J Clin Invest; 1990 Jan; 85(1):115-20. PubMed ID: 2136863
    [Abstract] [Full Text] [Related]

  • 2. Atrial natriuretic peptide lowers pulmonary arterial pressure in hypoxia-adapted rats.
    Jin HK, Yang RH, Thornton RM, Chen YF, Jackson R, Oparil S.
    J Appl Physiol (1985); 1988 Oct; 65(4):1729-35. PubMed ID: 2972675
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Atrial natriuretic peptide expression in rats with different pulmonary hypertensive responses to hypoxia.
    Klinger JR, Wrenn DS, Warburton RR, Pietras L, Ou LC, Hill NS.
    Am J Physiol; 1997 Jul; 273(1 Pt 2):H411-7. PubMed ID: 9249516
    [Abstract] [Full Text] [Related]

  • 7. Neutral endopeptidase inhibition attenuates development of hypoxic pulmonary hypertension in rats.
    Klinger JR, Petit RD, Warburton RR, Wrenn DS, Arnal F, Hill NS.
    J Appl Physiol (1985); 1993 Oct; 75(4):1615-23. PubMed ID: 8282611
    [Abstract] [Full Text] [Related]

  • 8. Neutral endopeptidase 24.11 inhibition reduces pulmonary vascular remodeling in rats exposed to chronic hypoxia.
    Winter RJ, Zhao L, Krausz T, Hughes JM.
    Am Rev Respir Dis; 1991 Dec; 144(6):1342-6. PubMed ID: 1835825
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Atrial natriuretic peptide ameliorates hypoxic pulmonary vasoconstriction without influencing systemic circulation.
    Höhne C, Drzimalla M, Krebs MO, Boemke W, Kaczmarczyk G.
    J Physiol Pharmacol; 2003 Dec; 54(4):497-510. PubMed ID: 14726606
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Atrial natriuretic peptide levels in plasma and in cardiac tissues after chronic hypoxia in rats.
    Winter RJ, Meleagros L, Pervez S, Jamal H, Krausz T, Polak JM, Bloom SR.
    Clin Sci (Lond); 1989 Jan; 76(1):95-101. PubMed ID: 2522033
    [Abstract] [Full Text] [Related]

  • 20. Developmental pattern of ventricular atrial natriuretic peptide (ANP) expression in chronically hypoxic rats as an indicator of the hypertrophic process.
    McKenzie JC, Kelley KB, Merisko-Liversidge EM, Kennedy J, Klein RM.
    J Mol Cell Cardiol; 1994 Jun; 26(6):753-67. PubMed ID: 8089855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.